Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
New York |
| State: |
|
New York |
| Zip Code: |
|
10065 |
| Conditions: |
|
Gastric Cancer - Pancreatic Cancer |
| Purpose: |
|
This study is being done to develop a new method that can rapidly stage patients with
gastric and pancreas cancer. Staging means finding out what is the extent of the cancer in a
patient's body.
Currently before patients have the surgery to remove their cancer, a surgical exam is done
in the operating room to see if their cancer has spread. A thin tube-like instrument with
lens and a light is placed into the abdomen. This is done by making small cuts into the
body. This exam is called a diagnostic laparoscopy. If cancer spread is not seen, fluid is
put into the abdomen and then taken out. This is called "lavage" or washing. The fluid is
then looked at in a laboratory. If the fluid contains cancer cells surgery is often delayed.
The investigators are testing a new method to put the fluid into the abdomen. It is called
percutaneous lavage. Percutaneous means "through the skin". A needle is put through the skin
into the abdomen. Tubing is then placed over the needle so that fluid can be put into the
abdomen and then taken out. The fluid is then looked at in a laboratory. The investigators
want to see if the two methods are equal because if they are equal, in the future, patients
may be able to have this procedure done outside of the operating room.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Men and women 18 years of age and older
- Informed consent in keeping with the policies of Memorial Sloan-Kettering Cancer
Center
- Presentation of gastric or pancreatic cancer based on objective findings by either:
- CT scan
- Endoscopy
- Pathologic examination
- Candidate for surgical treatment and are scheduled for laparoscopy with peritoneal
lavage.
Exclusion Criteria:
- Under 18 years of age
- Inability to speak or read English, and an appropriate translator is not identifiable
- Unable or unwilling to give informed consent
- Patients with synchronous cancers of other abdominal organs
- Multiple prior surgical procedures on the abdomen where the surgeon feels that
percutaneous lavage may be dangerous.
|
| NCT ID: |
|
NCT01132755 |
| Primary Contact: |
|
Principal Investigator
T. Peter Kingham, MD
Memorial Sloan-Kettering Cancer Center
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
New York, New York 10065
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|